{"id":5892,"date":"2024-12-05T07:10:42","date_gmt":"2024-12-05T13:10:42","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5892"},"modified":"2025-06-27T08:31:14","modified_gmt":"2025-06-27T13:31:14","slug":"ray-kaczmarek-joins-nanoscope","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/","title":{"rendered":"\u696d\u754c\u306e\u30d9\u30c6\u30e9\u30f3\u3067\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u306e\u5c02\u9580\u5bb6\u3067\u3042\u308b\u30ec\u30a4\u30fb\u30ab\u30c4\u30de\u30ec\u30af\u304c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u6700\u9ad8\u6280\u8853\u88fd\u9020\u8cac\u4efb\u8005\u306b\u5c31\u4efb"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<article class=\"news-release inline-gallery-template\">\n<section class=\"release-body container\">\n<div class=\"row\">\n<div class=\"col-lg-10 col-lg-offset-1\">\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">\u30c0\u30e9\u30b9<\/span><\/span>,\u00a0<span class=\"legendSpanClass\"><span class=\"xn-chron\">2024\u5e7412\u67085\u65e5<\/span><\/span>\u00a0\u2014 <a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4318063-1&h=3734763871&u=https%3A%2F%2Fnanostherapeutics.com%2F&a=Nanoscope+Therapeutics+Inc.\" target=\"_blank\" rel=\"nofollow noopener\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u304a\u3088\u3073\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u5f8c\u671f\u81e8\u5e8a\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u00a0<span class=\"xn-person\">\u30ec\u30a4\u30fb\u30ab\u30c4\u30de\u30ec\u30af<\/span>\u00a0\u304c\u6700\u9ad8\u6280\u8853\u88fd\u9020\u8cac\u4efb\u8005\u3068\u3057\u3066\u5f53\u793e\u306b\u5165\u793e\u3057\u307e\u3057\u305f\u3002\u30ab\u30c4\u30de\u30ec\u30af\u6c0f\u306f\u3001\u88fd\u85ac\u4f1a\u793e\u3084\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f1a\u793e\u3067\u696d\u52d9\u3001\u6280\u8853\u3001\u5546\u696d\u4f9b\u7d66\u6226\u7565\u3092\u4e3b\u5c0e\u3057\u3066\u304d\u305f\u6570\u5341\u5e74\u306e\u7d4c\u9a13\u3092\u6301\u3064\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u306e\u8457\u540d\u306a\u5c02\u9580\u5bb6\u3067\u3059\u3002<\/p>\n<p>\u201c\u300c\u30ec\u30a4\u306f\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u69cb\u7bc9\u3068\u7dad\u6301\u306b\u95a2\u3059\u308b\u8c4a\u5bcc\u306a\u5c02\u9580\u77e5\u8b58\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u5f7c\u306e\u904b\u55b6\u4e0a\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u306f\u3001\u5c06\u6765\u306e\u6cbb\u7642\u85ac\u306e\u5546\u696d\u4f9b\u7d66\u3092\u958b\u767a\u3057\u3001\u6f5c\u5728\u7684\u306a\u5546\u696d\u5316\u306b\u5411\u3051\u3066\u524d\u9032\u3059\u308b\u4e0a\u3067\u975e\u5e38\u306b\u91cd\u8981\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u300d\u3068\u8ff0\u3079\u305f\u3002\u00a0<span class=\"xn-person\">\u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4<\/span>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u5171\u540c\u5275\u8a2d\u8005\u517c\u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005\u3002<\/p>\n<p>\u30ab\u30c4\u30de\u30ec\u30af\u6c0f\u306f\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u696d\u754c\u306b\u304a\u3051\u308b\u7d4c\u55b6\u5e79\u90e8\u3068\u3057\u3066\u306e\u8c4a\u5bcc\u306a\u7d4c\u9a13\u3068\u696d\u52d9\u306e\u5c02\u9580\u77e5\u8b58\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u76f4\u8fd1\u3067\u306f\u3001\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u30d7\u30ed\u30bb\u30b9\u958b\u767a\u3001GMP\u88fd\u9020\u3001\u5206\u6790\u30b5\u30fc\u30d3\u30b9\u306b\u7279\u5316\u3057\u305fCDMO\uff08\u53d7\u8a17\u958b\u767a\u88fd\u9020\u7d44\u7e54\uff09\u3067\u3042\u308bGenezen\u306e\u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002Genezen\u306e\u524d\u306f\u3001\u6838\u9178\u3001GMP\u30ad\u30e3\u30c3\u30d4\u30f3\u30b0\u8a66\u85ac\u3001\u30d7\u30e9\u30b9\u30df\u30c9\u3001\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u306e\u5408\u6210\u306b\u7279\u5316\u3057\u305fCDMO\u3067\u3042\u308bMaravai Lifesciences\u306e\u4e00\u90e8\u9580\u3067\u3042\u308bTriLink Biotechnologies\u3067GMP\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u526f\u793e\u9577\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u975e\u30aa\u30d4\u30aa\u30a4\u30c9\u93ae\u75db\u5264\u304a\u3088\u3073\u518d\u751f\u533b\u7642\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u5927\u624b\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u3067\u3042\u308bPacira Biosciences\u3067\u88fd\u9020\u304a\u3088\u3073\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u526f\u793e\u9577\u3092\u52d9\u3081\u3001\u305d\u308c\u4ee5\u524d\u306f\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306b\u7279\u5316\u3057\u305fCDMO\u3067\u3042\u308bNitto Avecia\u306e\u793e\u9577\u3092\u52d9\u3081\u3066\u3044\u307e\u3057\u305f\u3002\u30ab\u30c4\u30de\u30ec\u30af\u6c0f\u306f\u3001\u00a0<span class=\"xn-org\">\u30d0\u30fc\u30b8\u30cb\u30a2\u5de5\u79d1\u5927\u5b66<\/span>\u00a0\u305d\u3057\u3066\u30a2\u30e1\u30ea\u30ab\u9678\u8ecd\u306e\u8a87\u308a\u3042\u308b\u9000\u5f79\u8ecd\u4eba\u3067\u3059\u3002<\/p>\n<p>\u201c\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306f\u3001\u9769\u65b0\u7684\u306a\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u54c1\u3092\u5e02\u5834\u306b\u6295\u5165\u3059\u308b\u3068\u3044\u3046\u4f7f\u547d\u306b\u304a\u3044\u3066\u3001\u6975\u3081\u3066\u91cd\u8981\u306a\u5c40\u9762\u3092\u8fce\u3048\u3066\u3044\u307e\u3059\u300d\u3068\u30ab\u30c1\u30de\u30ec\u30af\u6c0f\u306f\u8ff0\u3079\u307e\u3057\u305f\u3002\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u79c1\u306e\u5c02\u9580\u77e5\u8b58\u3092\u63d0\u4f9b\u3067\u304d\u308b\u3053\u3068\u3092\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u304c\u3053\u308c\u3089\u306e\u5207\u671b\u3055\u308c\u3066\u3044\u308b\u6cbb\u7642\u6cd5\u3092\u60a3\u8005\u306b\u5c4a\u3051\u3089\u308c\u308b\u3088\u3046\u3001\u5546\u696d\u751f\u7523\u4f53\u5236\u306e\u69cb\u7bc9\u3092\u4e3b\u5c0e\u3057\u3066\u3044\u304f\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201d<\/p>\n<p><b>Nanoscope Therapeutics, Inc. \u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u6cbb\u7642\u6cd5\u306e\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bRESTORE\u30d5\u30a7\u30fc\u30ba2b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\uff09\u3001\u540c\u793e\u306f\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/10\/nanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa\/\" target=\"_blank\" rel=\"nofollow noopener\">RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>\u00a0\u540c\u793e\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02025\u5e74\u7b2c1\u56db\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001RP\u3068Stargardt\u306e\u4e21\u65b9\u3067FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p><b>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b><br class=\"dnr\" \/>\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br class=\"dnr\" \/>212-600-1902<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p>\n<p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"<p>DALLAS,\u00a0Dec. 5, 2024\u00a0\u2014 Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and geographic atrophy (GA), today announced that\u00a0Ray Kaczmarek\u00a0has joined the company as Chief Technology and Manufacturing Officer. Mr. Kaczmarek is a recognized expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotechnology companies. \u201cRay brings a wealth of expertise in building and sustaining gene therapy manufacturing programs. His operational leadership will be crucial to developing the commercial supply of our future therapies as we advance towards potential commercialization,\u201d said\u00a0Sulagna Bhattacharya, Co-founder and Chief Executive Officer of Nanoscope. Mr. Kaczmarek has an extensive [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5895,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5892","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-05T13:10:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T13:31:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer\",\"datePublished\":\"2024-12-05T13:10:42+00:00\",\"dateModified\":\"2025-06-27T13:31:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/\"},\"wordCount\":450,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/NSCOPE_LI_Kaczmarke_V3FIN.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/\",\"name\":\"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/NSCOPE_LI_Kaczmarke_V3FIN.jpg\",\"datePublished\":\"2024-12-05T13:10:42+00:00\",\"dateModified\":\"2025-06-27T13:31:14+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/NSCOPE_LI_Kaczmarke_V3FIN.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/NSCOPE_LI_Kaczmarke_V3FIN.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/12\\\/05\\\/ray-kaczmarek-joins-nanoscope\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u696d\u754c\u306e\u30d9\u30c6\u30e9\u30f3\u3067\u3042\u308a\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u306e\u5c02\u9580\u5bb6\u3067\u3042\u308b\u30ec\u30a4\u30fb\u30ab\u30ba\u30de\u30ec\u30af\u6c0f\u304c\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u6700\u9ad8\u6280\u8853\u30fb\u88fd\u9020\u8cac\u4efb\u8005\u3068\u3057\u3066\u5165\u793e - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/","og_locale":"ja_JP","og_type":"article","og_title":"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-12-05T13:10:42+00:00","article_modified_time":"2025-06-27T13:31:14+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer","datePublished":"2024-12-05T13:10:42+00:00","dateModified":"2025-06-27T13:31:14+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/"},"wordCount":450,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/","url":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/","name":"\u696d\u754c\u306e\u30d9\u30c6\u30e9\u30f3\u3067\u3042\u308a\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u306e\u5c02\u9580\u5bb6\u3067\u3042\u308b\u30ec\u30a4\u30fb\u30ab\u30ba\u30de\u30ec\u30af\u6c0f\u304c\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u6700\u9ad8\u6280\u8853\u30fb\u88fd\u9020\u8cac\u4efb\u8005\u3068\u3057\u3066\u5165\u793e - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg","datePublished":"2024-12-05T13:10:42+00:00","dateModified":"2025-06-27T13:31:14+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/12\/NSCOPE_LI_Kaczmarke_V3FIN.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/12\/05\/ray-kaczmarek-joins-nanoscope\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Industry Veteran and Gene Therapy Manufacturing Expert, Ray Kaczmarek, Joins Nanoscope as Chief Technical and Manufacturing Officer"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5892"}],"version-history":[{"count":5,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5892\/revisions"}],"predecessor-version":[{"id":9008,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5892\/revisions\/9008"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5895"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}